生殖補助医療技術の市場規模、シェア、成長分析：タイプ別、最終用途別、地域別 - 産業予測 2025～2032年

生殖補助医療技術市場規模は2023年に359億2,000万米ドルとなり、予測期間（2025～2032年）のCAGRは8.3%で、2024年の389億米ドルから2032年には736億2,000万米ドルに成長する見通しです。

生殖補助医療技術（ART）の世界市場は、不妊率の上昇、不妊治療や代理出産に対する意識の高まりにより、大きな成長を遂げています。ARTには、体外受精（IVF）や妊娠代理出産を含むさまざまな方法が含まれ、個人やカップルの妊娠を支援するように設計されています。世界保健機関（WHO）は、2020年には約4,800万組のカップルと1億8,600万人の個人が不妊症の診断に直面すると推定しており、こうしたサービスの必要性の大きさを強調しています。さらに、疾病対策予防センターは、PCOSを持つアメリカ人女性の6％から12％も不妊症に悩んでいると強調し、需要をさらに押し上げています。官民両部門からの資金援助と継続的な技術進歩により、ART市場の将来性は引き続き堅調です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

生殖補助医療技術市場規模：タイプ別

• 市場概要
• 体外受精（IVF）
• 人工授精
• その他

生殖補助医療技術市場規模：最終用途別

• 市場概要
• 不妊治療クリニック
• 病院
• その他

生殖補助医療技術市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Merck KGaA（Germany）
• Cook Medical（USA）
• Vitrolife AB（Sweden）
• CooperSurgical, Inc.（USA）
• Irvine Scientific（USA）
• Ferring Pharmaceuticals（Switzerland）
• Genea Limited（Australia）
• Cryolab Ltd.（UK）
• Bloom IVF Center（India）
• Cosmos Biomedical Ltd.（UK）
• European Sperm Bank（Denmark）
• Parallabs（UK）
• Microm UK Ltd.（UK）
• Esco Medical（Singapore）
• IVFtech ApS（Denmark）
• The Cooper Companies, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）

結論と提言

Assisted Reproductive Technology Market size was valued at USD 35.92 billion in 2023 and is poised to grow from USD 38.9 billion in 2024 to USD 73.62 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global market for Assisted Reproductive Technology (ART) is experiencing significant growth due to rising infertility rates and increased awareness of fertility treatments and surrogacy. ART encompasses a range of methods including in vitro fertilization (IVF) and gestational surrogacy, designed to assist individuals and couples in conceiving. The World Health Organization estimates that in 2020, approximately 48 million couples and 186 million individuals faced infertility diagnoses, emphasizing the scale of the need for these services. Additionally, the Centers for Disease Control and Prevention highlight that 6% to 12% of American women with PCOS also struggle with infertility, further propelling demand. With funding from both public and private sectors and ongoing technological advancements, the ART market's prospects remain robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Assisted Reproductive Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Assisted Reproductive Technology Market Segments Analysis

Global Assisted Reproductive Technology Market is segmented by Type, End-Use and region. Based on Type, the market is segmented into In-Vitro Fertilization (IVF), Artificial Insemination and Others. Based on End-Use, the market is segmented into Fertility Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Assisted Reproductive Technology Market

The rise in infertility rates, driven by factors like delayed childbirth, lifestyle modifications, and environmental influences, underscores the growing importance of Assisted Reproductive Technology (ART). As more couples seek solutions for their infertility issues, there is a corresponding increase in demand for ART services. This heightened interest not only highlights the need for viable reproductive options but also propels the growth of the ART industry, making it a vital component of modern reproductive health solutions. Consequently, the trend indicates a significant expansion potential for ART, reflecting society's evolving approach to family building in the face of fertility challenges.

Restraints in the Assisted Reproductive Technology Market

One of the primary challenges facing the Assisted Reproductive Technology (ART) market is the high cost associated with treatments such as in vitro fertilization (IVF) and other related procedures. These substantial expenses can limit accessibility and affordability for many patients, ultimately hindering the overall growth of the market, especially in areas that lack robust healthcare infrastructure. As a result, the financial burden can prevent individuals from seeking necessary ART services, thereby stifling market expansion in regions where the demand for such technologies exists but is unmet due to prohibitive costs.

Market Trends of the Assisted Reproductive Technology Market

The Assisted Reproductive Technology (ART) market is witnessing a significant trend towards the expansion of personalized solutions, bolstered by advancements in genetic screening and embryo analysis. This shift towards individualized ART therapies is driven by the desire to enhance overall success rates and optimize treatment efficiency. By addressing specific causes of infertility and tailoring approaches to meet individual patient needs, healthcare providers can offer more targeted and effective fertility treatments. As a result, this trend not only improves patient outcomes but also fosters continued innovation in the reproductive health sector, reflecting an evolving landscape that prioritizes personalized care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Advancement

Global Assisted Reproductive Technology Market Size by Type & CAGR (2025-2032)

• Market Overview
• In-Vitro Fertilization (IVF)
• Artificial Insemination
• Others

Global Assisted Reproductive Technology Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Fertility Clinics
• Hospitals
• Others

Global Assisted Reproductive Technology Market Size & CAGR (2025-2032)

• North America (Type, End-Use)
  • US
  • Canada
• Europe (Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryolab Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom IVF Center (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmos Biomedical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• European Sperm Bank (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parallabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microm UK Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVFtech ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Cooper Companies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations